Landos Biopharma Inc (LABP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||
| Net Income | -10,573 | 5,796 | -13,467 |
| Depreciation Amortization | 139 | 65 | 103 |
| Accounts payable and accrued liabilities | 1,731 | 2,792 | N/A |
| Other Working Capital | 1,092 | 2,533 | 3,277 |
| Other Operating Activity | -1,581 | -14,554 | 213 |
| Operating Cash Flow | $-9,192 | $-3,368 | $-9,874 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -79 | -20 | -158 |
| Purchase Of Investment | -10,092 | -1,251 | N/A |
| Sale Of Investment | 13,908 | 2,978 | N/A |
| Other Investing Activity | 0 | 0 | -40,167 |
| Investing Cash Flow | $3,737 | $1,707 | $-40,325 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 0 | 0 | 59,648 |
| Financing Cash Flow | $N/A | $N/A | $59,648 |
| Exchange Rate Effect | -46 | N/A | 0 |
| Beginning Cash Position | 9,808 | 9,808 | 359 |
| End Cash Position | 4,307 | 8,147 | 9,808 |
| Net Cash Flow | $-5,501 | $-1,661 | $9,449 |
| Free Cash Flow | |||
| Operating Cash Flow | -9,192 | -3,368 | -9,874 |
| Capital Expenditure | -79 | -20 | N/A |
| Free Cash Flow | -9,271 | -3,388 | -9,874 |